This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hampil, B. Articles by Melnick, J. L. Search for Related Content PubMed Articles by Hampil, B. Articles by Melnick, J. L. Agricola Articles by Hampil, B. Articles by Melnick, J. L.

 Previous Article  |  Next Article 

Appl Environ Microbiol. 1969 January; 17(1): 17-20
Copyright © 1969 American Society for Microbiology. All Rights Reserved.

Method for Testing Virus Stocks for Viral Contaminants

World Health Organization International Reference Centre for Enteroviruses, Department of Virology and Epidemiology, Baylor University College of Medicine, Houston, Texas 77025

ABSTRACT

A practical method for testing the purity of virus stocks has been developed and applied to reference stocks of enteroviruses. The method requires the use of a reference antiserum that is substantially free from heterotypic antibody. When selected dilutions of this antiserum are reacted with high concentrations of virus, virus intentionally allowed to escape neutralization is recovered and then identified. A contaminating virus present as a minor component of the population has a far greater probability of being revealed under the conditions of this "breakthrough" test than under the commonly used virus identity tests which customarily employ approximately 100 TCD₅₀ of virus and, therefore, only identify the major component of the virus population. The breakthrough test described has been used for tests of 104 reference stocks of all the enteroviruses that propagate in monkey kidney cells and human amnion cells. Although all the materials had been previously tested and approved by the commonly employed virus identity test, the breakthrough test in two instances revealed contaminating heterotypic enteroviruses present at a very low titer in the stocks. Without resorting to the stringent, elaborate, and expensive tests for absolute purity, such as those that are required to assure safety of vaccines, the use of the breakthrough test described provides reasonable assurance of purity for stock viruses to be employed as diagnostic reagents or for general laboratory research purposes where a multiplicity of viral agents and antisera are required.